Amidst the ongoing COVID-19 outbreak, our way of life has changed drastically. How can we tell places you visit or people you meet are COVID free? How will companies protect their employees and create a safe workplace?
Applying tests for every single person will be a must in the New Normal Society? Will we all have an easy access to these newly developed medical kits soon?
On May 19, Andy Chang, APAC Regional Senior Director of our Corporate Member IGENOMIX offered us answers to these questions and many others in a webinar session specially organised for the SpCCJ Members.
Igenomix is a Spanish reproductive and fertility bio-tech company, which has been working on COVID-19 testing for private usage, by applying their know-how in genetics. Igenomix has recently launched the FDA-EUA approved COVID-19 RT-PCR Test and also introduced the Igenomix Biological Passport, a combination of new COVID-19 RT-PCR diagnostic test and a COVID-19 serological antibody test.
